Pediatric Hypertension¶
Learning Objectives¶
Core Knowledge & Clinical Reasoning¶
- [ ] Apply 2017 AAP BP classification criteria (elevated BP, Stage 1, Stage 2) using appropriate tables
- [ ] Determine when to transition from pediatric percentile-based to adult threshold-based criteria (age ≥13)
- [ ] Analyze clinical and laboratory findings to differentiate primary from secondary hypertension
- [ ] Evaluate indications for ambulatory BP monitoring (ABPM) and interpret results
Pharmacotherapy¶
- [ ] Select appropriate first-line antihypertensive therapy based on etiology and comorbidities
- [ ] Formulate dose titration and monitoring plan for antihypertensive medications
Communication & Counseling¶
- [ ] Counsel families on lifestyle modifications (diet, exercise, weight management, sodium restriction)
- [ ] Discuss long-term cardiovascular risk associated with childhood hypertension
Systems-Based Practice¶
- [ ] Coordinate evaluation for secondary causes with appropriate subspecialties (nephrology, endocrine)
- [ ] Ensure appropriate BP measurement technique is used (correct cuff size, positioning)
Key Guidelines¶
2017 AAP Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents Pediatrics. 2017;140(3):e20171904
Key Changes from 2004 Fourth Report¶
- "Elevated BP" replaces "prehypertension"
- NEW normative BP tables based on normal-weight children only
- Simplified screening table for primary care
- Age ≥13 years: Use adult criteria (120/80 threshold)
- BP screening only at preventive care visits
- Expanded role for ABPM
- Updated medication recommendations
- Treatment goal: <90th percentile (or <130/80 for adolescents ≥13)
BP Classification¶
Children 1-12 Years (Use Pediatric Tables)¶
| Category | Systolic AND/OR Diastolic |
|---|---|
| Normal | <90th percentile |
| Elevated BP | ≥90th to <95th percentile OR 120/<80 (whichever is lower) |
| Stage 1 HTN | ≥95th percentile to <95th + 12 mmHg OR 130/80 to 139/89 |
| Stage 2 HTN | ≥95th percentile + 12 mmHg OR ≥140/90 |
Adolescents ≥13 Years (Use Adult Criteria)¶
| Category | Systolic | Diastolic |
|---|---|---|
| Normal | <120 | AND <80 |
| Elevated BP | 120-129 | AND <80 |
| Stage 1 HTN | 130-139 | OR 80-89 |
| Stage 2 HTN | ≥140 | OR ≥90 |
Measurement Technique¶
- Appropriate cuff size (bladder width 40% of arm circumference)
- Seated, back supported, feet on floor
- Right arm preferred (coarctation detection)
- 3-5 minutes of rest before measurement
- Auscultatory method preferred for diagnosis confirmation
- Oscillometric devices require validation
Evaluation¶
When to Evaluate¶
- Elevated BP on 3 separate occasions
- Stage 2 HTN at initial visit warrants immediate evaluation
Initial Workup (All Children with HTN)¶
- History: diet, activity, sleep, medications, family history
- Physical exam: including 4-extremity BP (rule out coarctation)
- Labs: BMP, urinalysis, lipid panel, CBC
- Renal ultrasound (if <6 years or abnormal UA/renal function)
Extended Workup (Secondary HTN Suspected)¶
- Plasma renin/aldosterone
- Urine catecholamines
- Thyroid function
- Drug screen
- Polysomnography (if OSA suspected)
- Renal artery Doppler or CTA/MRA
ABPM Indications¶
- Confirm HTN before starting therapy
- White coat hypertension suspected
- Masked hypertension suspected
- High-risk conditions (CKD, diabetes, s/p CoA repair)
- Assess efficacy of antihypertensive treatment
- Clinical symptoms suggesting hypertension
ABPM Interpretation¶
- Ambulatory HTN: Mean SBP or DBP ≥95th percentile
- Load: % readings above threshold (>25% abnormal)
- Dipping: Normal = 10-20% drop during sleep
Management¶
Lifestyle Modifications (All Patients)¶
- Weight loss if overweight/obese
- DASH diet
- Regular aerobic exercise (30-60 min/day)
- Limit sedentary activities (<2 hrs screen time)
- Adequate sleep
Pharmacotherapy Indications¶
- Stage 1 HTN + symptoms or target organ damage
- Stage 2 HTN
- Stage 1 HTN persistent despite lifestyle modifications
- HTN with diabetes, CKD, or heart disease
First-Line Medications¶
| Class | Examples | Notes |
|---|---|---|
| ACE inhibitors | Lisinopril, enalapril | Preferred if proteinuria, DM |
| ARBs | Losartan | ACEi alternative |
| CCBs | Amlodipine | Good for primary HTN |
| Thiazide diuretics | Chlorthalidone, HCTZ | Good for primary HTN |
Treatment Goals¶
- Children: <90th percentile
- Adolescents ≥13: <130/80
- CKD with proteinuria: <50th percentile
2023 ESH Guidelines Comparison¶
| Feature | AAP 2017 | ESH 2023 |
|---|---|---|
| Adult criteria age | ≥13 years | ≥16 years |
| BP tables | Normal-weight only | Include overweight |
| Classification | Similar | Similar |
Board Pearls¶
Pearl: Use adult criteria (120/80) starting at age 13
Per 2017 AAP guidelines; ESH uses 16 years
Pearl: 2017 tables use NORMAL-WEIGHT children only
Major change from 2004 Fourth Report
Pearl: ABPM before starting medication
Confirm diagnosis; rule out white coat HTN
Self-Assessment¶
Q1: A 10-year-old has BP readings of 122/76, 118/74, and 120/78 on three visits. Height is 50th percentile. How is this classified?
Answer
**Answer**: Elevated BP **Rationale**: For children <13 years, use the pediatric tables. The 95th percentile for a 10-year-old at 50th height percentile is approximately 122/82. Readings consistently ≥90th percentile but <95th percentile = Elevated BP. Note: if 120/<80 is lower than the 90th percentile, use 120/<80 as the threshold.Q2: A 15-year-old has BP of 134/82. What is the classification and initial management?
Answer
**Answer**: Stage 1 hypertension; lifestyle modifications with repeat measurement **Rationale**: At ≥13 years, use adult criteria. 130-139/80-89 = Stage 1 HTN. Initial management includes lifestyle modifications with repeat BP measurements. If persistent without symptoms or target organ damage, may observe with lifestyle changes before medication.Related Topics¶
References¶
- Flynn JT, et al. Pediatrics. 2017;140(3):e20171904
- ESH 2023 Guidelines. J Hypertens. 2023